The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update

L. B. Ramsey; S. G. Johnson; K. E. Caudle; C. E. Haidar; D. Voora; R. A. Wilke; W. D. Maxwell; L. McLeod; R. M. Krauss; D. M. Roden; Q. Feng; R. M. Cooper-DeHoff; L. Gong; T. E. Klein; M. Wadelius; Mikko Niemi

doi:10.1038/clpt.2014.125

The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update

L. B. Ramsey, S. G. Johnson, K. E. Caudle, C. E. Haidar, D. Voora, R. A. Wilke, W. D. Maxwell, L. McLeod, R. M. Krauss, D. M. Roden, Q. Feng, R. M. Cooper-DeHoff, L. Gong, T. E. Klein, M. Wadelius, Mikko Niemi

Research output: Contribution to journal › Article › Scientific › peer-review

Original language	English
Journal	Clinical Pharmacology and Therapeutics
Volume	96
Issue number	4
Pages (from-to)	423-428
Number of pages	6
ISSN	0009-9236
DOIs	https://doi.org/10.1038/clpt.2014.125
Publication status	Published - Oct 2014
MoE publication type	A1 Journal article-refereed

Fields of Science

STATIN-INDUCED MYOPATHY
HIGH-RISK INDIVIDUALS
OATP-C
CONTROLLED-TRIAL
GENETIC VARIANT
PHARMACOKINETICS
ROSUVASTATIN
DRUG
POLYMORPHISMS
SLCO1B1-ASTERISK-5
3111 Biomedicine

Access to Document

10.1038/clpt.2014.125

Cite this

Ramsey, L. B., Johnson, S. G., Caudle, K. E., Haidar, C. E., Voora, D., Wilke, R. A., Maxwell, W. D., McLeod, L., Krauss, R. M., Roden, D. M., Feng, Q., Cooper-DeHoff, R. M., Gong, L., Klein, T. E., Wadelius, M., & Niemi, M. (2014). The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update. Clinical Pharmacology and Therapeutics, 96(4), 423-428. https://doi.org/10.1038/clpt.2014.125

@article{f85b6809a62e4e228bb3492cdd059797,

title = "The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update",

keywords = "STATIN-INDUCED MYOPATHY, HIGH-RISK INDIVIDUALS, OATP-C, CONTROLLED-TRIAL, GENETIC VARIANT, PHARMACOKINETICS, ROSUVASTATIN, DRUG, POLYMORPHISMS, SLCO1B1-ASTERISK-5, 3111 Biomedicine",

author = "Ramsey, \{L. B.\} and Johnson, \{S. G.\} and Caudle, \{K. E.\} and Haidar, \{C. E.\} and D. Voora and Wilke, \{R. A.\} and Maxwell, \{W. D.\} and L. McLeod and Krauss, \{R. M.\} and Roden, \{D. M.\} and Q. Feng and Cooper-DeHoff, \{R. M.\} and L. Gong and Klein, \{T. E.\} and M. Wadelius and Mikko Niemi",

year = "2014",

month = oct,

doi = "10.1038/clpt.2014.125",

language = "English",

volume = "96",

pages = "423--428",

journal = "Clinical Pharmacology and Therapeutics",

issn = "0009-9236",

publisher = "Wiley Blackwell",

number = "4",

}

Ramsey, LB, Johnson, SG, Caudle, KE, Haidar, CE, Voora, D, Wilke, RA, Maxwell, WD, McLeod, L, Krauss, RM, Roden, DM, Feng, Q, Cooper-DeHoff, RM, Gong, L, Klein, TE, Wadelius, M & Niemi, M 2014, 'The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update', Clinical Pharmacology and Therapeutics, vol. 96, no. 4, pp. 423-428. https://doi.org/10.1038/clpt.2014.125

TY - JOUR

T1 - The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy

T2 - 2014 Update

AU - Ramsey, L. B.

AU - Johnson, S. G.

AU - Caudle, K. E.

AU - Haidar, C. E.

AU - Voora, D.

AU - Wilke, R. A.

AU - Maxwell, W. D.

AU - McLeod, L.

AU - Krauss, R. M.

AU - Roden, D. M.

AU - Feng, Q.

AU - Cooper-DeHoff, R. M.

AU - Gong, L.

AU - Klein, T. E.

AU - Wadelius, M.

AU - Niemi, Mikko

PY - 2014/10

Y1 - 2014/10

KW - STATIN-INDUCED MYOPATHY

KW - HIGH-RISK INDIVIDUALS

KW - OATP-C

KW - CONTROLLED-TRIAL

KW - GENETIC VARIANT

KW - PHARMACOKINETICS

KW - ROSUVASTATIN

KW - DRUG

KW - POLYMORPHISMS

KW - SLCO1B1-ASTERISK-5

KW - 3111 Biomedicine

U2 - 10.1038/clpt.2014.125

DO - 10.1038/clpt.2014.125

M3 - Article

SN - 0009-9236

VL - 96

SP - 423

EP - 428

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

IS - 4

ER -